Reiko Shimizu graduated from Tokyo Women’s Medical University, Tokyo, Japan, in 1993, and Ph.D. degrees in Pediatrics from Tokyo Women’s Medical University, Tokyo, Japan, in 1997.
In 1998, she joined the Department of Pediatrics, Tokyo Women’s Medical University, as an instructor. In 2010, she joined the research Fellow in Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh U.S.A. After that, she belongs to National Center of Neurology and Psychiatry (NCNP) as Research associate of Clinical Research Support office in 2012, and joined the team of clinical development of Duchenne muscular dystrophy. Since 2014, She had worked as medical reviewer of offices of new drug III and vaccines in Pharmaceuticals and Medical Device Agency. Since January 2010, she has been with researcher of clinical research support office and also contribute to office of ethical committee in NCNP. Her current interests include clinical research, medical genetics, pediatric neurology, and regulatory science. She is the member of Japan Paediatric Society, Japan Society of Human Genetics and Japan Paediatric Neurology Society.